A detailed history of Russell Investments Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 856,820 shares of AZN stock, worth $55.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
856,820
Previous 856,571 0.03%
Holding current value
$55.2 Million
Previous $66.8 Million 0.06%
% of portfolio
0.1%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $19,090 - $21,817
249 Added 0.03%
856,820 $66.8 Million
Q2 2024

Aug 08, 2024

BUY
$66.81 - $80.83 $5.27 Million - $6.38 Million
78,921 Added 10.15%
856,571 $66.8 Million
Q1 2024

May 08, 2024

SELL
$61.03 - $69.57 $31.9 Million - $36.4 Million
-522,956 Reduced 40.21%
777,650 $52.7 Million
Q4 2023

Feb 05, 2024

BUY
$61.89 - $69.28 $21.2 Million - $23.7 Million
342,185 Added 35.7%
1,300,606 $87.6 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $11.6 Million - $12.9 Million
179,575 Added 23.06%
958,421 $64.9 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $1.47 Million - $1.59 Million
-21,015 Reduced 2.63%
778,846 $55.7 Million
Q1 2023

May 09, 2023

BUY
$63.15 - $71.6 $1.86 Million - $2.11 Million
29,429 Added 3.82%
799,861 $55.5 Million
Q4 2022

Feb 08, 2023

SELL
$54.21 - $70.44 $1.39 Million - $1.8 Million
-25,571 Reduced 3.21%
770,432 $52.2 Million
Q3 2022

Nov 04, 2022

SELL
$53.02 - $135.75 $14.7 Million - $37.6 Million
-276,674 Reduced 25.79%
796,003 $43.6 Million
Q2 2022

Jul 29, 2022

BUY
$59.26 - $71.14 $3.06 Million - $3.67 Million
51,601 Added 5.05%
1,072,677 $70.9 Million
Q1 2022

May 05, 2022

SELL
$55.72 - $67.12 $11.7 Million - $14.1 Million
-209,768 Reduced 17.04%
1,021,076 $67.7 Million
Q4 2021

Jan 21, 2022

SELL
$54.02 - $63.83 $22.2 Million - $26.2 Million
-410,659 Reduced 25.02%
1,230,844 $71.7 Million
Q3 2021

Nov 08, 2021

BUY
$55.56 - $60.79 $46.2 Million - $50.5 Million
831,375 Added 102.62%
1,641,503 $98.6 Million
Q2 2021

Aug 04, 2021

BUY
$48.42 - $60.18 $9.45 Million - $11.7 Million
195,154 Added 31.73%
810,128 $48.5 Million
Q1 2021

May 10, 2021

SELL
$47.16 - $54.44 $12.2 Million - $14.1 Million
-259,209 Reduced 29.65%
614,974 $30.6 Million
Q4 2020

Feb 08, 2021

BUY
$48.52 - $58.02 $6.03 Million - $7.21 Million
124,333 Added 16.58%
874,183 $43.7 Million
Q3 2020

Nov 09, 2020

BUY
$53.07 - $61.1 $2.38 Million - $2.74 Million
44,817 Added 6.36%
749,850 $41.1 Million
Q2 2020

Aug 05, 2020

SELL
$43.1 - $55.31 $9.46 Million - $12.1 Million
-219,440 Reduced 23.74%
705,033 $37.3 Million
Q1 2020

May 06, 2020

SELL
$37.79 - $51.33 $27.4 Million - $37.2 Million
-724,821 Reduced 43.95%
924,473 $41.3 Million
Q4 2019

Jan 29, 2020

SELL
$42.46 - $50.46 $13.1 Million - $15.6 Million
-309,198 Reduced 15.79%
1,649,294 $82.3 Million
Q3 2019

Nov 01, 2019

BUY
$40.12 - $45.47 $4.97 Million - $5.64 Million
123,962 Added 6.76%
1,958,492 $87.5 Million
Q2 2019

Aug 09, 2019

BUY
$37.28 - $41.68 $13.4 Million - $15 Million
359,884 Added 24.4%
1,834,530 $75.6 Million
Q1 2019

May 13, 2019

BUY
$35.49 - $43.02 $6.83 Million - $8.28 Million
192,559 Added 15.02%
1,474,646 $60.2 Million
Q4 2018

Feb 11, 2019

SELL
$36.86 - $41.49 $659,351 - $742,173
-17,888 Reduced 1.38%
1,282,087 $48.6 Million
Q3 2018

Oct 26, 2018

BUY
$34.76 - $39.72 $33.6 Million - $38.4 Million
966,461 Added 289.78%
1,299,975 $51.5 Million
Q2 2018

Aug 08, 2018

SELL
$34.55 - $37.05 $3.4 Million - $3.65 Million
-98,528 Reduced 22.81%
333,514 $11.7 Million
Q1 2018

May 11, 2018

SELL
$32.97 - $36.63 $7.43 Million - $8.25 Million
-225,343 Reduced 34.28%
432,042 $15.1 Million
Q4 2017

Feb 06, 2018

SELL
$32.09 - $34.78 $38.5 Million - $41.7 Million
-1,198,755 Reduced 64.58%
657,385 $22.4 Million
Q3 2017

Nov 07, 2017

BUY
$28.96 - $34.0 $53.8 Million - $63.1 Million
1,856,140
1,856,140 $62.9 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.